1.350SEK-0.74%Mkt Cap: 155.13M SEKP/E: —Last update: 2026-06-01
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involv…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap155.13M SEK
Enterprise Value125.61M SEK
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-47.65M SEK
Revenue/Share—
Last Price1.350 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.33
PEG—
EV/EBITDA-2.15
EV/Revenue—
P/S—
P/B13.88
EPS (TTM)-0.55
EPS (Forward)-0.12
52W Range
1.3001% of range4.950
52W High4.950 SEK
52W Low1.300 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-144.75%
ROA-80.71%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-34.59M SEK
CapEx (TTM)—
FCF Margin—
FCF Yield-11.50%
Net Debt-30.68M SEK
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity0.08
Current Ratio1.36
Quick Ratio1.30
Book Value/Sh0.0980 SEK
Cash/Share0.2870 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 SEK
Target Range5.000 SEK – 5.000 SEK
# Analysts1
Ownership
Shares Out.114.91M
Float69.17M
Insiders42.95%
Institutions9.07%
Technical
SMA 501.481 (-8.9%)
SMA 2002.090 (-35.4%)
Beta-0.04
S&P 52W Chg27.70%
Avg Vol (30d)127.53K
Avg Vol (10d)92.71K
Technical Indicators
RSI (14)42.6
MACD-0.0320
MACD Signal-0.0367
MACD Hist.+0.0047
BB Upper1.491 SEK
BB Middle1.407 SEK
BB Lower1.322 SEK
BB Width11.95%
ATR (14)0.0847 SEK
Vol Ratio (20d)0.29x